TheraVectys SA is considering an initial public offering in Hong Kong, according to people familiar with the matter, a rare move for a non-Chinese biotech firm despite a wave of listings in the Asian financial hub.
www.bloomberg.com
#TheraVectys #Mull #Hong #Kong #IPO #Rare #Move #NonChinese #Biotech #Firm
TheraVectys Is Said to Mull Hong Kong IPO in Rare Move for Non-Chinese Biotech Firm
